MCF Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-100
Closed -$10K 497
2019
Q3
$10K Hold
100
﹤0.01% 368
2019
Q2
$9K Hold
100
﹤0.01% 361
2019
Q1
$9K Sell
100
-400
-80% -$35K ﹤0.01% 356
2018
Q4
$32K Hold
500
0.01% 249
2018
Q3
$45K Hold
500
0.01% 223
2018
Q2
$40K Sell
500
-95
-16% -$7.89K 0.01% 231
2018
Q1
$53K Buy
595
+500
+526% +$48K 0.01% 211
2017
Q4
$10K Hold
95
﹤0.01% 339
2017
Q3
$14K Hold
95
﹤0.01% 322
2017
Q2
$12K Hold
95
﹤0.01% 356
2017
Q1
$12K Hold
95
﹤0.01% 345
2016
Q4
$11K Sell
95
-31
-25% -$3.45K ﹤0.01% 310
2016
Q3
$13K Sell
126
-700
-85% -$75.8K ﹤0.01% 304
2016
Q2
$81K Buy
826
+731
+769% +$75.6K 0.02% 177
2016
Q1
$10K Hold
95
﹤0.01% 335
2015
Q4
$11K Hold
95
﹤0.01% 327
2015
Q3
$10K Buy
+95
New +$11.8K ﹤0.01% 326
2014
Q3
Sell
-800
Closed -$112K 487
2014
Q2
$112K Buy
+800
New +$60.8K 0.04% 130

Other funds holding CELG

MCF Advisors's CELG Position: Q4 2019 in Review

MCF Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 100 shares — an estimated $10K sold.

MCF Advisors first reported a position in CELG in Q2 2014 and held it in 18 quarters. The position peaked at $112K in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • MCF Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • MCF Advisors sold 100 Celgene Corp shares in Q4 2019, an estimated $10K.
  • MCF Advisors first reported a position in Celgene Corp in Q2 2014 and held it in 18 quarters.
  • MCF Advisors's Celgene Corp position peaked at $112K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on MCF Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.